| Baphomet vs Clive | 27–40 | 40.30% |
| Baphomet vs Reina | 34–20 | 62.96% |
| Baphomet vs Dragunov | 20–32 | 38.46% |
| Baphomet vs King | 17–24 | 41.46% |
| Baphomet vs Kazuya | 19–12 | 61.29% |
| Baphomet vs Lili | 15–15 | 50.00% |
| Baphomet vs Jin | 14–12 | 53.85% |
| Baphomet vs Heihachi | 8–18 | 30.77% |
| Baphomet vs Bryan | 10–14 | 41.67% |
| Baphomet vs Victor | 12–12 | 50.00% |
| Baphomet vs Paul | 6–17 | 26.09% |
| Baphomet vs Asuka | 10–13 | 43.48% |
| Baphomet vs Lars | 12–9 | 57.14% |
| Baphomet vs Devil Jin | 6–11 | 35.29% |
| Baphomet vs Azucena | 5–11 | 31.25% |
| Baphomet vs Hwoarang | 10–5 | 66.67% |
| Baphomet vs Jack-8 | 6–9 | 40.00% |
| Baphomet vs Lidia | 7–7 | 50.00% |
| Baphomet vs Alisa | 5–7 | 41.67% |
| Baphomet vs Yoshimitsu | 3–8 | 27.27% |
| Baphomet vs Nina | 4–6 | 40.00% |
| Baphomet vs Leo | 3–6 | 33.33% |
| Baphomet vs Jun | 3–6 | 33.33% |
| Baphomet vs Steve | 4–4 | 50.00% |
| Baphomet vs Claudio | 6–2 | 75.00% |
| Baphomet vs Leroy | 6–2 | 75.00% |
| Baphomet vs Xiaoyu | 2–5 | 28.57% |
| Baphomet vs Shaheen | 1–5 | 16.67% |
| Baphomet vs Kuma | 3–3 | 50.00% |
| Baphomet vs Law | 2–3 | 40.00% |
| Baphomet vs Raven | 0–4 | 0.00% |
| Baphomet vs Feng | 0–2 | 0.00% |
| Baphomet vs Lee | 1–1 | 50.00% |
| Baphomet vs Zafina | 2–0 | 100.00% |
| Baphomet vs Eddy | 0–2 | 0.00% |
| Baphomet vs Panda | 1–0 | 100.00% |
Limitations
This data is often requested to give insight into which characters you have more trouble with than others, but it is not particularly helpful for that. The main issue is that it is heavily skewed by how strong the opponents you play are.
For example, this data suggests my worst matchup is clearly vs Reina, but that's just because most of those games are vs Yagami.
There is a way to account for this being worked on. The central idea is to assign each matchup a rating vs you which adjusts based on the result, much like the regular rating but also based on the rating of each player. With this, it would give a better summary of how well you perform vs each character.
In the meantime, this page is here to present the data as requested.